XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Loss for the period $ (7,672,266) $ (4,270,506)
Adjustments to reconcile loss for the period to net cash used in operating activities:    
Depreciation 50,341 41,951
Stock-based compensation 2,072,030 55,405
Remeasurement adjustment of warrants issued to placement agent 211,077
Change in the fair value of Warrants with down-round protection (240,613) (110,498)
Linkage difference on principal of loans from stockholders 373 27
Changes in assets and liabilities:    
(Increase) in accounts receivable (18,748) (51,356)
Decrease in inventory 49,255 170,274
Decrease in other current assets 256,997 157,149
(Decrease) increase in accounts payable 235,138 (815,795)
Increase in other current liabilities 170,632 265,983
Decrease in liability for employee rights upon retirement (10,148)
Net cash used in operating activities (5,107,009) (4,346,289)
Cash flows from investing activities:    
Purchase of property and equipment (19,467) (75,269)
Net cash used in investing activities (19,467) (75,269)
Cash flows from financing activities:    
Cash dividend on Series A Preferred Stock (5,143) (13,529)
Proceeds allocated to Series C Preferred Stock, net of cash issuance expenses 3,598,254 3,021,063
Proceeds allocated to Series C Warrants, net of cash issuance expenses 1,780,963 1,496,077
Net cash provided by financing activities 5,374,074 4,503,611
Effect of exchange rate changes on cash and cash equivalents 65,274 5,405
Increase in cash and cash equivalents 312,872 87,458
Cash and cash equivalents at beginning of the period 148,836 608,701
Cash and cash equivalents at end of the period $ 461,708 $ 696,159